BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25312015)

  • 1. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
    Baird JK; Dewi M; Subekti D; Elyazar I; Satyagraha AW
    Transl Res; 2015 Jun; 165(6):677-88. PubMed ID: 25312015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
    Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
    Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
    Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
    Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
    PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
    Espino FE; Bibit JA; Sornillo JB; Tan A; von Seidlein L; Ley B
    PLoS One; 2016; 11(2):e0148172. PubMed ID: 26849445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
    Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
    Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
    Baird K
    Pathog Glob Health; 2015 May; 109(3):93-106. PubMed ID: 25943156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
    Baird JK
    BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor.
    Swastika M; Harahap AR; Panggalo LV; Jusman SWA; Satyagraha AW
    Malar J; 2020 Jun; 19(1):208. PubMed ID: 32552815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
    Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
    Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
    Adu-Gyasi D; Asante KP; Newton S; Dosoo D; Amoako S; Adjei G; Amoako N; Ankrah L; Tchum SK; Mahama E; Agyemang V; Kayan K; Owusu-Agyei S
    PLoS One; 2015; 10(4):e0125796. PubMed ID: 25885097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
    Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
    Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
    Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
    PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests.
    Kahn M; LaRue N; Bansil P; Kalnoky M; McGray S; Domingo GJ
    Malar J; 2013 Aug; 12():286. PubMed ID: 23961874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
    Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
    PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
    Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
    Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.